Key facts
- This page summarizes Angela Gill Nelms's Form 4 filing for RenovoRx, Inc. (RNXT).
- 2 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 04 Oct 2023, 16:44.
Angela Gill Nelms - 03 Oct 2023 Form 4 Insider Report for RenovoRx, Inc. (RNXT)
- Reporting relationship
- Chief Operating Officer
- Issuer ticker
- RNXT
- Reported as of
- 03 Oct 2023
- Net transaction value
- +$1,151
- SEC form
- 4
- Accepted by SEC
- 04 Oct 2023, 16:44:34 UTC
- Prior SEC filing
- 29 Mar 2023
- Next SEC filing
- 23 Jan 2024
- Source filing
- View source filing
- Reporting owner signature
- /s/ Angela Nelms
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Angela Gill Nelms filed Form 4 for RenovoRx, Inc. (RNXT) on 04 Oct 2023.
Change
- Previous filing in this sequence was filed on 29 Mar 2023.
- Current net transaction value: +$1,151.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
RNXT
transaction
Common Stock
Purchase
- Transaction value
- $315
- Shares
- +300
- Change %
- Price
- $1.05
- Shares after
- 300
- Date
- 03 Oct 2023
- Ownership
- Direct
RNXT
transaction
Common Stock
Purchase
- Transaction value
- $836
- Shares
- +800
- Change %
- +267%
- Price
- $1.04
- Shares after
- 1,100
- Date
- 03 Oct 2023
- Ownership
- Direct
* marks a reported price that did not pass the local price check.